chrisvoncsefalvay/vaers-outcomes huggingface dataset:
"Felt like my heart went out of my chest"; Joint Pain; vomiting; Chills; Fatigue; headache; Muscle pain; arm swollen and itch (Left); This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 29-Mar-2021 and was forwarded to Moderna on 29-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS ("Felt like my heart went out of my chest"), ARTHRALGIA (Joint Pain), VOMITING (vomiting), CHILLS (Chills) and FATIGUE (Fatigue) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced PALPITATIONS ("Felt like my heart went out of my chest"), ARTHRALGIA (Joint Pain), VOMITING (vomiting), CHILLS (Chills), FATIGUE (Fatigue), HEADACHE (headache), MYALGIA (Muscle pain) and INJECTION SITE SWELLING (arm swollen and itch (Left)). At the time of the report, PALPITATIONS ("Felt like my heart went out of my chest"), ARTHRALGIA (Joint Pain), VOMITING (vomiting), CHILLS (Chills), FATIGUE (Fatigue), HEADACHE (headache), MYALGIA (Muscle pain) and INJECTION SITE SWELLING (arm swollen and itch (Left)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided.  No treatment medication was provided.   Most recent FOLLOW-UP information incorporated above includes: On 29-Mar-2021: Non-Significant Follow-up
severe headache; nausea; severe sore sensation; flu-like symptoms; felling like her throat was closing; cold; obstruction sensation on her chest; cough; This is a spontaneous report from a contactable consumer or other non-HCP.  A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), dose 2 via an unspecified route of administration on an unspecified date as single dose for covid-19 immunization. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported),  via an unspecified route of administration on an unspecified date as single dose for covid-19 immunization and developed some soreness in her arm.The patient medical history and concomitant medications were not reported. On an unspecified date, 4 days after receiving the second dose she developed: severe headache, severe sore sensation, nausea, flu-like symptoms, felling like her throat was closing and cold and obstruction sensation on her chest, she constantly have to cough to get this feeling off and get some type of relief. She mentioned that she wont be getting a new shot of the vaccine in 6 months as does not have information on for how long would provide protection.The outcome of events was unknown.
Headache, chills, slight nausea and body aches. Headache  went away after 12 hours. Chills after 8 hours. Body aches ended exactly 24 hours from onset (the following night at 9pm).
Swelling, redness, mild tenderness left upper arm 1 day after injection little itchy worse next day 2.
9/24/2022 1255 -Residents skin color noted to be ashen and resident is alert verbal and complains of chest pain. BP 79/66 p 120 02 sat 91%b. Resident placed on 02 at 2 lmp. via N/C . Ambulance service contacted to transport resident to ER. 02 sat % 85% at present. Resident remains alert and continues to complain of chest pain. 9/24/22- Resident admitted to Hospital with DX of pneumonia and sepsis, resident placed on vent. 9/25/2022 resident passed away
He had an infection, a UTI, Sepsis; He had an infection, a UTI, Sepsis; walking to the car when he started shaking; he felt freezing; This is a spontaneous report from a contactable consumer. This consumer reported for a male patient (reporter's husband). A male patient of an unspecified age received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Report's husband who got his first vaccine at the same time (unknown date reported as two and a half weeks ago) as the reporter, she was walking to the car when the patient started shaking and said he felt freezing on unknown date. Later that night reporter had to call an ambulance. He was rushed to ER (emergency room) and hospitalized for 5 days. The patient had an infection, a UTI, Sepsis. He did not know had a UTI and the doctors believe that between the COVID vaccine and infection the two went crazy and beat up on each other. The patient was in the hospital for five days after his COVID shot. It was a combination of an infection and he didn't know and didn't have any symptoms. The two just clashed. He was very sensitive about it. He was feeling better and clean and clear. He was getting the second one. The outcome of events was recovering.  Information about lot/batch number has been requested.
Taking antibiotics because of a bladder infection; This spontaneous case was reported by a pharmacist and describes the occurrence of CYSTITIS (Taking antibiotics because of a bladder infection) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CYSTITIS (Taking antibiotics because of a bladder infection). At the time of the report, CYSTITIS (Taking antibiotics because of a bladder infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication and treatment information was  not reported.
Developed hives on face, red and watering eyes, hoarseness, SOB,abdominal pain, chest discomfort, urticaria on face and trunk after immunizations were given.  After a few minutes pt c/o tightness in his chest. MO auscultated wheezing in bilat lower lung lobes.  Pt received Yellow Fever, IPV, Twinrix, and Typhoid Fever. MO gave 50mg IM Benadryl with little relief to patient, when wheezing began, MO ordered O2, IV line, 500ml of NS bolus and 0.3mg Epinephrine given SC.  When EMS arrived pt still had tightness in chest and abdomen but the uticaria was improved.  EMS gave him an albuterol nebulizer during transport to hospital.
Severe thrombocytopenia, transaminitis, followed by worsening AKI and death.
herpes zoster; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. The patient's concurrent conditions, medical history and concomitant medications were not reported. On or about 03-JUL-2012, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (dose, dose#, lot#, expiration date and route of administration were not provided) for the long-term prevention of shingles and/or zoster-related conditions at the pharmacy. Subsequent to patient's inoculation, the patient was treated by a healthcare provide for herpes zoster. As a direct and proximate result of patient's use of zoster vaccine live (ZOSTAVAX) vaccine, the patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).
pt recv vax & 3 days later pt devel chicken pox w/hundreds of lesions;
This case was reported by a other health professional via call center representative and described the occurrence of syncope vasovagal in a 17-year-old male patient who received BEXSERO (batch number 16B601, expiry date 29th February 2020) for prophylaxis. Concomitant products included MENVEO. On 15th August 2018, the patient received the 1st dose of BEXSERO (intramuscular) .5 ml. On 15th August 2018, less than a minute after receiving BEXSERO, the patient experienced syncope vasovagal. On an unknown date, the outcome of the syncope vasovagal was recovered/resolved. It was unknown if the reporter considered the syncope vasovagal to be related to BEXSERO. Additional details were provided as follows: On 15th August 2018, the patient received MENVEO (batch number M17077, expiry date 30th July 2019) in the left deltoid. At 13:00, the patient received BEXSERO in the right deltoid. Within 30 seconds after receiving BEXSERO, the patient experienced vasovagal syncope which resolved within 30 to 45 seconds.
Whole left side of body is numb, face feels paralyzed I can?t feel it ,  my arm is asleep I can barley feel my Hand and also my I kinda feel swollen from my leg and knee
Erythematous blanching wheal 11x7 cm with raised border central induration 3x3 cm central blanching 2x2 mm at injection site.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider, a pharmacist, recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. In 2016, a pharmacist administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). In 2017, the patient was treated by a physician for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death; aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
Information has been received from a nurse referring to a male patient of unknown age. There was no pertinent medical history, concurrent condition, concomitant medication or drug allergy described. On an unspecified date in November, 2015, the patient was administered a dose of improperly stored dose of RECOMBIVAX HB lot # K019502, expiration date unspecified (strength, dose and route were not reported). The vaccine was stored under an unspecified temperature for 3 weeks. No adverse effect reported. This is one of several reports received from the same source. Additional information has been requested.
About a month after I got 2nd dose of Covid vaccine Pfizer, I sometimes feel there is a needle pinching my heart and left arm. I also feel like a needle pinching my nerve and bone many times since. There are couple times around December 2021, I felt a sudden heart/chest/left arm pain and couldn't deep breath for a short time. I did call my Cardio Doctor office but they didn't have available appointment for me so they advised me to go to emergency room. However, the pain gone so I didn't go. Even though I've been having irregular heart beat before vaccine, however, I have never felt like these before. So, my concern is maybe the vaccine Pfizer has made my heart, nerve, and bone having issues? I'm wonder. I haven't talked to my Doctor about my wonder because I just thought about it today. However, I did go to my Doctor on 1/21/2022 and tell him my symptoms and he ordered me some test. I will have those tests done soon. I still feel pinching on my chest and bones sometimes.
pt recv vax 26APR96 & pt devel an inj site rxn, characterized by redness & itching;additional info was recv 26JUN96;pt recv tx w/DPH & topic recovered;
she "felt aching under her arm/armpit"/it became painful; swelling below the arm crease and a hard lump; swelling below the arm crease and a hard lump; swelling and itching at the injection site; swelling and itching at the injection site; This is a spontaneous report from a contactable consumer or other non hcp. A 37-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration on 27Mar2021(at 37-years of age) as DOSE 2, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The historical vaccine includes bnt162b2(PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration on an unspecified date (at 37-years of age) as DOSE 1, SINGLE for COVID-19 immunisation. On an unspecified date the patient felt aching under her arm/armpit/it became painful, swelling below the arm crease and a hard lump, swelling and itching at the injection site. The events outcome was reported as unknown.   No follow-up attempts are possible. No further information is expected.
Fever, cough, body aches, dizziness, red eyes, flushed cheeks
flu vaccine given by co-worker CRNA in a mall or fluvax clinic on 9/23/00@0845. Injection was placed high in L arm @ Subacromial space per employee. She felt immediate severe pain @ site which lasted @ that intensity for two days before lessening but still present almost 5 wks later - worse in last week no redness swelling or bruising. Pain with certain movements of L arm and especially 5/10 @ night - a constant ache. No prior L arm problems. Pt is right handed - referred to shoulder specialist
The first day I had chills and fatigue about 6 hours after the shot. The next morning I woke up and the room was spinning and I had severe muscle aches. I had to call off work. I went back to bed and slept 13 hours and then felt fine.
03/14/2021: Presented to the emergency department post fall on right hip. The patient underwent a surgical repair of a right hip femoral neck fracture. Patient remains admitted, but no complications/adverse events noted.
Patient was admitted to the hospital within 6 weeks of receiving COVID vaccination. This occurred on both 3/23/21 and 4/1/21.
Patient developed raised red area surrounding injection site shortly after administration. Patient has taken BENADRYL to treat. Site is warm to touch and extends from deltoid to about 3 inches above elbow. It persists 6 days after injection but had lightened in color.
Information has been received from an 81 year old female with no medical history or allergies who was vaccinated with a 0.65 ml dose of zoster vaccine live (Oka/Merck). It was reported that 2 months after vaccination the patient developed shingles. Unspecicifed medical attention was sought. No diagnostic laboratory tests were undertaken. At the time of report the patient had not recovered. A product quality complaint was not involved. No further information is expected.
I am a 27 year old female with no medical conditions. Received my first Moderna shot Friday 5:30 pm, and I felt fine immediately afterwards but developed a sore arm (at injection site) within 2-3 hours, which intensified Saturday. No redness nor swelling in the arm, just the pain. Saturday I had stronger arm pain accompanied by constant neck pain, lymph node pain and headache. I also experienced random intermittent pains in the left chest (I have occasionally experienced chest pain in the past), side (left), and lower back. After these appeared I experienced what felt like an anxiety attack, with uncontrollable crying, shortness of breath and worry. My partner helped calm me. Today, Sunday, body aches are gone minus the sore arm, for which the pain is about 75% reduced.
Patient was complete in her Meningo series and did not need Menveo. She needed her 2nd dose of Bexsero.
3 days of fever, extreme exhaustion, swollen lymph nodes, and blistery rash on hands and feet. In addition to that she experienced sharp, random, radiating pain from shoulders through both hands during that time. Plus site of injection was still swollen and sore ten days later.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 75-year-old male patient received BNT162b2 (BNT162B2), on 01Mar2021 at 10:00 as dose 1, single (Batch/Lot number: unknown), in left arm, on 29Mar2021 at 10:00 as dose 2, single (Batch/Lot number: unknown), in left arm, on 22Nov2021 at 19:00 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm and on 26Apr2022 at 19:00 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 75 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hypertrophic Cardiomyopathy" (unspecified if ongoing); "implanted defibrillator in place" (unspecified if ongoing), notes: implanted defibrillator in place; "cholecystectomy" (unspecified if ongoing), notes: 10 years ago; "benign hypertrophic prostate" (unspecified if ongoing), notes: benign hypertrophic prostate; "skin cancer" (unspecified if ongoing), notes: surgically treated skin cancer 8 years ago. There were no concomitant medications.  The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results. Therapeutic measures were taken as a result of drug ineffective, suspected covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE NON ST ELEVATION MI ACUTE MI
Left arm red, hot, and swollen. Redness was spreading so she was given antibiotic by MD.
Family called in to triage nurse at clinic 3/30/23 that patient had increased swelling and pain to right thigh with reduced motion of right thigh, more than expected with previous vaccines.  No respiratory distress or GI distress.
A report has been received from a Health Professional concerning a 16 year old, Female subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST started on 09-Jan-2014. The Registered Nurse reported that they accidentally gave expired FLUMIST on 09-Jan-2014. Patient had not reported any symptoms. The outcome of the event of accidentally gave expired FLUMIST is unknown. The report was considered to be non-serious.
L thigh swelling with 10x15cm erythema 5x5cm induration and redness.
Approximately 5 minutes after vaccination patient started slumping in chair.  He was helped to the floor by his companion.  He had blurred vision and mild shaking and kept asking what is going on.  He was asked to lay down on the floor but chose to remain sitting on the floor.  He was given a cold compress for his neck and stayed seated on the floor until he felt better.  He stated that he was not dizzy, lightheaded but felt really tired.  He recovered and stayed for about 15 minutes after recovering.  He declined any medical attention and had a ride with his companion.  He was advised to seek medical attention at the ER.
The vial expired on 01-Apr-2022 that was initially stored in the refrigerator on 04-Apr-2022 and then administered on 15-Apr-2022; Expired vaccine administered to patient; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient) and PRODUCT STORAGE ERROR (The vial expired on 01-Apr-2022 that was initially stored in the refrigerator on 04-Apr-2022 and then administered on 15-Apr-2022) in a 79-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 15-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial expired on 01-Apr-2022 that was initially stored in the refrigerator on 04-Apr-2022 and then administered on 15-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient) and PRODUCT STORAGE ERROR (The vial expired on 01-Apr-2022 that was initially stored in the refrigerator on 04-Apr-2022 and then administered on 15-Apr-2022) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Number of doses/vials: 80 doses administered. On 04APR2022, the vial  was initially stored in refrigerator.  The vial did not undergo any temperature excursions. The pharmacy was trying to verify the expiration date. Reported that when the pharmacy received the vaccine, a staff member came up with expiration date of June 2022. However, another staff member looked up the expiration date as 01APR2022.  No treatment medications were reported.
Muscle Aches in Head , neck, legs, back.   Flu like symptoms, headache. Afebrile. Started 4/2/05. Advised to seek medical attention.